Mpl W515/S505 Mutation Analysis Test, Blood in Sangli
50+ booked in last 3 daysOverview
The "MPL W515/S505 Mutation Analysis, Blood" test is used to detect mutations in the MPL gene, specifically in Codon W515 and Codon S505. Its clinical utility lies in suspected cases of essential thrombocythemia (ET) and primary myelofibrosis (PMF) where the presence of the Jak2 V617F mutation is negative. Essential thrombocythemia and primary myelofibrosis are myeloproliferative neoplasms characterized by abnormal blood cell production. The Jak2 V617F mutation is commonly associated with these conditions, but in some cases, it may not be present, leading to diagnostic uncertainty. In such situations, testing for MPL mutations becomes crucial, as detecting mutations in Codon W515 and Codon S505 can confirm the diagnosis of ET or PMF. Identifying these MPL mutations provides valuable diagnostic information, enabling accurate classification and management of these hematological disorders.
Mpl W515/S505 Mutation Analysis Test, Blood Price in Sangli
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Mpl W515/S505 Mutation Analysis Test, Blood with a clear pricing structure
The price of Mpl W515/S505 Mutation Analysis Test, Blood in Sangli is ₹ 6,275
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.